Dr. Agarwal's Health Care Limited

HealthcareHealthcareHealthcare ServicesHospital

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹485.90
Market cap
15,345 Cr
Stock P/E
95.5
P/B
0.00
Dividend yield
0.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025
Sales431 Cr460 Cr487 Cr499 Cr530 Cr
Operating expenses (approx.)316 Cr332 Cr360 Cr363 Cr386 Cr
EBITDA115 Cr128 Cr128 Cr136 Cr144 Cr
OPM %26.7%27.9%26.2%27.3%27.2%
Other income13 Cr15 Cr13 Cr8 Cr11 Cr
Interest28 Cr25 Cr25 Cr23 Cr21 Cr
Depreciation58 Cr60 Cr63 Cr68 Cr69 Cr
Profit before tax41 Cr59 Cr54 Cr54 Cr65 Cr
Tax %31.1%27.3%29.0%32.0%32.6%
Net profit28 Cr43 Cr38 Cr36 Cr44 Cr
EPS (₹)₹0.73₹1.04₹0.95₹0.94₹1.07

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025TTM
Sales1,711 CrSign in for TTM
Operating expenses (approx.)1,258 CrSign in for TTM
EBITDA453 CrSign in for TTM
OPM %26.5%Sign in for TTM
Other income46 CrSign in for TTM
Interest109 CrSign in for TTM
Depreciation231 CrSign in for TTM
Profit before tax160 CrSign in for TTM
Tax %31.0%Sign in for TTM
Net profit110 CrSign in for TTM
EPS (₹)₹2.80Sign in for TTM
Dividend payout %0.7%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025
Equity capital32 Cr
Reserves1,835 Cr
Borrowings247 Cr
Other liabilities1,498 Cr
Total liabilities3,672 Cr
Fixed assets (net)708 Cr
CWIP144 Cr
Investments264 Cr
Other assets794 Cr
Total assets3,672 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025
Cash from operating activity360 Cr
Cash from investing-750 Cr
Cash from financing382 Cr
Net cash flow-8 Cr
Free cash flow (OCF − Capex)52 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025
ROCE %10.2%
ROE %4.3%
Debtor days26
Inventory days24761
Days payable47212
Cash conversion cycle-22424
Debt / equity0.13
Current ratio1.66
Net debt / EBITDA0.32

Compare with peers

Loading peers…